NDC 70518-4495-00 - Metronidazole
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4495
- Requested NDC
- 70518-4495-00
- Package NDCs from labels
- 70518-4495-0, 70518-4495-00
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metronidazole - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-09-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4495-0 | Metronidazole | 70 g in 1 TUBE, WITH APPLICATOR | GEL | 70 | 1 | |
| 70518-4495-0 | Metronidazole | 1 in 1 CARTON | GEL | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | 2f7d84d4-1085-4243-be88-442eecb85205 | 2026-11-06 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Hospira, Inc. | 49360d6f-c8b3-420e-af75-154cf7b05255 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | 8f1de4ca-a005-4ca9-a43a-380429c80d6f | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | 4cdd7ac5-a52c-4766-afeb-1b5e567a328c | 2026-10-14 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | aea4e2a1-2089-40dc-9eee-deaab4f21397 | 2026-10-14 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | PD-Rx Pharmaceuticals, Inc. | b85bdc1f-1ffb-40d5-a407-e8de2891996d | 2026-10-14 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | WG Critical Care, LLC | e4ea0c09-cdd1-4708-962c-6ba28b989df3 | 2026-10-06 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | cc004be0-da13-4b6b-83d5-d45b23fd37c9 | 2026-10-06 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole Vaginal Gel | METRONIDAZOLE | Aurobindo Pharma Limited | 2ced2460-a003-4314-897b-f4ae0ff72edf | 2026-10-01 | Warnings, Adverse reactions | 142046 140QMO216E |
| METRONIDAZOLE | METRONIDAZOLE | Henry Schein, Inc. | df7df946-c83f-4adf-9007-aff4f757a665 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | 2a6f8d77-a5b7-40fb-9a2e-e2778c39ba01 | 2026-09-14 | Warnings, Adverse reactions | ANDA213648 70518-4495-0 70518-4495 70518449500 142046 5b72f53d-b858-bb90-e063-6294a90a89e0 2a6f8d77-a5b7-40fb-9a2e-e2778c39ba01 140QMO216E |
| Metronidazole | METRONIDAZOLE | Cardinal Health 107, LLC | 9ed89bfc-ccf3-4e6c-924f-2a14bf82163f | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals, Inc. | 4040db14-750f-6d20-e054-00144ff8d46c | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Major Pharmaceuticals | 71f5ce2f-17f8-45fc-b27d-2bf982591ab3 | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | 5cc3fd98-d579-432e-a4b5-b6d5586991a6 | 2026-08-05 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Sagent Pharmaceuticals | d46870f5-e2b1-46bd-8413-4a0a8bcf3175 | 2026-08-05 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | dc28753c-95ec-4b41-ad77-c4a66698d9db | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | b49a8ad0-2cf9-4386-8bf5-1b1df87b0022 | 2026-08-03 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | d5784eeb-6b99-4e8a-847b-b0d1090ed48a | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Vagizole | METRONIDAZOLE | iNutrition LLC | fd5e884b-cf07-493b-bb93-039bbb0c4784 | 2026-07-22 | Warnings, Adverse reactions | ANDA213648 142046 140QMO216E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.